Market Cap 9.98B
Revenue (ttm) 4.05B
Net Income (ttm) 22.20M
EPS (ttm) N/A
PE Ratio 19.24
Forward PE 19.87
Profit Margin 0.55%
Debt to Equity Ratio 0.64
Volume 241,900
Avg Vol 984,430
Day's Range N/A - N/A
Shares Out 49.22M
Stochastic %K 90%
Beta 1.63
Analysts Strong Sell
Price Target $201.93

Company Profile

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of serv...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 781 222 6000
Address:
251 Ballardvale Street, Wilmington, United States
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 25 at 2:27 AM
$CRL RSI: 76.98, MACD: 7.0817 Vol: 9.07, MA20: 190.28, MA50: 181.59 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 4:33 PM
Actionable Trade Alert for $CRL: Market Context: $CRL is currently trading at $193.85, showing strong upward momentum but nearing overbought territory with an RSI of 69.75. The price is above both the 30-day MA (177.64) and the 50-day MA (178.67), indicating bullish sentiment. However, caution is warranted as the RSI suggests potential for a pullback. Directional Bias: Given the recent high of $200.58, $CRL has room to move higher, but the proximity to overbought conditions may lead to volatility. Trade Plan: - Suggested Entry: $193.85 - Stop Loss: $185.00 (approximately 4.6% below entry) - Take Profit Targets: - Target 1: $200.00 (3.2% gain) - Target 2: $205.00 (5.7% gain) - Target 3: $227.00 (17% gain) With a clear strategy in place, traders can capitalize on potential gains while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Dec. 18 at 3:18 PM
Is $CRL positioned for growth despite fierce competition? 🤔 Charles River’s large research model product revenues thrived with a 6.5% organic revenue boost in Q3 2025, but macro headwinds and a competitive landscape loom large. However, its strategic partnerships and strong solvency offer a cushion. 📈 Opportunity assessment here 👉 https://www.zacks.com/stock/news/2806011/should-you-continue-to-hold-crl-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2806011-body-25419&ADID=SYND_STOCKTWITS_TWEET_2_2806011_BODY_25419
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 1:13 PM
Mizuho updates rating for Charles River ( $CRL ) to Neutral, target set at 174 → 200.
0 · Reply
ZacksResearch
ZacksResearch Dec. 18 at 12:41 PM
Hold or trim $CRL — is now the moment of truth? ⚖️ The question isn’t about buying — it’s whether CRL still earns its spot in your portfolio for now, signaling a potential inflection point investors can’t ignore. See the full hold-or-sell breakdown here 👉 https://www.zacks.com/stock/news/2806011/should-you-continue-to-hold-crl-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2806011-teaser-25351&ADID=SYND_STOCKTWITS_TWEET_2_2806011_TEASER_25351
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 3:19 AM
Actionable Trade Alert for $CRL Market Context: $CRL is currently trading at $195.22, showing strong momentum but is overbought with an RSI of 78.57. The stock is above its 30-day MA of 176.54 and 50-day MA of 177.78, indicating bullish sentiment. However, the high of $200.58 suggests potential resistance. Directional Bias: Given the RSI level, there may be a short-term pullback before further gains. The price is within a tight range between the 60D high of $200.58 and low of $144.26, suggesting volatility. Trade Plan: - Suggested Entry: $195.22 - Stop Loss: $188.00 (approx. 3.5% risk) - Take Profit Targets: 1. $200.00 (2.9% gain) 2. $205.00 (5.0% gain) 3. $229.00 (17.3% gain) With the potential for a significant ROI on the third target, monitor for price action closely. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 8:58 PM
Barclays updates rating for Charles River ( $CRL ) to Overweight, target set at 210 → 215.
0 · Reply
RunnerSignals
RunnerSignals Dec. 15 at 8:22 PM
$ASH $CRL $CVX stock upgrades today with near-term gains possible https://stocksrunner.com/news/2025-12-15-stock-upgrades-today-show-top-picks
0 · Reply
erevnon
erevnon Dec. 15 at 7:48 PM
JP Morgan maintains Charles River $CRL at Neutral and raises the price target from $165 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 7:07 PM
JP Morgan has updated their rating for Charles River ( $CRL ) to Neutral with a price target of 190.
0 · Reply
Latest News on CRL
Madison Small Cap Fund Q3 2025 Portfolio Activity

Nov 21, 2025, 8:35 AM EST - 4 weeks ago

Madison Small Cap Fund Q3 2025 Portfolio Activity

EXP HXL SAIA


Charles River Beat Expectations But Why Is The Stock Falling?

Nov 5, 2025, 1:38 PM EST - 7 weeks ago

Charles River Beat Expectations But Why Is The Stock Falling?


Charles River: Mixed Q3 As Strategic Review Disappoints

Nov 5, 2025, 12:33 PM EST - 7 weeks ago

Charles River: Mixed Q3 As Strategic Review Disappoints


Why Charles River Stock May Struggle In Its Final Phase

Oct 7, 2025, 7:22 AM EDT - 2 months ago

Why Charles River Stock May Struggle In Its Final Phase


Charles River: Margin Fears Outweigh Solid Q2

Aug 6, 2025, 12:47 PM EDT - 5 months ago

Charles River: Margin Fears Outweigh Solid Q2


Charles River Laboratories Announces First-Quarter 2025 Results

May 7, 2025, 7:01 AM EDT - 8 months ago

Charles River Laboratories Announces First-Quarter 2025 Results


OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 25 at 2:27 AM
$CRL RSI: 76.98, MACD: 7.0817 Vol: 9.07, MA20: 190.28, MA50: 181.59 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 4:33 PM
Actionable Trade Alert for $CRL: Market Context: $CRL is currently trading at $193.85, showing strong upward momentum but nearing overbought territory with an RSI of 69.75. The price is above both the 30-day MA (177.64) and the 50-day MA (178.67), indicating bullish sentiment. However, caution is warranted as the RSI suggests potential for a pullback. Directional Bias: Given the recent high of $200.58, $CRL has room to move higher, but the proximity to overbought conditions may lead to volatility. Trade Plan: - Suggested Entry: $193.85 - Stop Loss: $185.00 (approximately 4.6% below entry) - Take Profit Targets: - Target 1: $200.00 (3.2% gain) - Target 2: $205.00 (5.7% gain) - Target 3: $227.00 (17% gain) With a clear strategy in place, traders can capitalize on potential gains while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Dec. 18 at 3:18 PM
Is $CRL positioned for growth despite fierce competition? 🤔 Charles River’s large research model product revenues thrived with a 6.5% organic revenue boost in Q3 2025, but macro headwinds and a competitive landscape loom large. However, its strategic partnerships and strong solvency offer a cushion. 📈 Opportunity assessment here 👉 https://www.zacks.com/stock/news/2806011/should-you-continue-to-hold-crl-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2806011-body-25419&ADID=SYND_STOCKTWITS_TWEET_2_2806011_BODY_25419
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 1:13 PM
Mizuho updates rating for Charles River ( $CRL ) to Neutral, target set at 174 → 200.
0 · Reply
ZacksResearch
ZacksResearch Dec. 18 at 12:41 PM
Hold or trim $CRL — is now the moment of truth? ⚖️ The question isn’t about buying — it’s whether CRL still earns its spot in your portfolio for now, signaling a potential inflection point investors can’t ignore. See the full hold-or-sell breakdown here 👉 https://www.zacks.com/stock/news/2806011/should-you-continue-to-hold-crl-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2806011-teaser-25351&ADID=SYND_STOCKTWITS_TWEET_2_2806011_TEASER_25351
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 3:19 AM
Actionable Trade Alert for $CRL Market Context: $CRL is currently trading at $195.22, showing strong momentum but is overbought with an RSI of 78.57. The stock is above its 30-day MA of 176.54 and 50-day MA of 177.78, indicating bullish sentiment. However, the high of $200.58 suggests potential resistance. Directional Bias: Given the RSI level, there may be a short-term pullback before further gains. The price is within a tight range between the 60D high of $200.58 and low of $144.26, suggesting volatility. Trade Plan: - Suggested Entry: $195.22 - Stop Loss: $188.00 (approx. 3.5% risk) - Take Profit Targets: 1. $200.00 (2.9% gain) 2. $205.00 (5.0% gain) 3. $229.00 (17.3% gain) With the potential for a significant ROI on the third target, monitor for price action closely. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 8:58 PM
Barclays updates rating for Charles River ( $CRL ) to Overweight, target set at 210 → 215.
0 · Reply
RunnerSignals
RunnerSignals Dec. 15 at 8:22 PM
$ASH $CRL $CVX stock upgrades today with near-term gains possible https://stocksrunner.com/news/2025-12-15-stock-upgrades-today-show-top-picks
0 · Reply
erevnon
erevnon Dec. 15 at 7:48 PM
JP Morgan maintains Charles River $CRL at Neutral and raises the price target from $165 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 7:07 PM
JP Morgan has updated their rating for Charles River ( $CRL ) to Neutral with a price target of 190.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 6:52 AM
Actionable Trade Alert for $CRL: Market Context: $CRL is currently trading at $193.03, exhibiting strong momentum with an RSI of 81.03, indicating overbought conditions. The stock is above its 30-day MA of 175.86 and 50-day MA of 177.31, suggesting bullish sentiment. However, the high RSI signals potential for a pullback. Directional Bias: Given the current price is near the 60D high of 199.66, we anticipate a possible retracement before any further upward movement. Trade Plan: - Suggested Entry: $193.03 - Stop Loss: $188.00 (below recent support) - Take Profit Targets: 1. $198.00 (2.5% gain) 2. $202.00 (4.6% gain) 3. $226.00 (17% gain) This plan allows for a strategic entry while managing risk effectively. Monitor the RSI and price action closely for potential adjustments. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 11:46 PM
Actionable Trade Alert for $CRL: Market Context: $CRL is currently trading at $193.34, showing strong momentum. The RSI at 83.86 indicates the stock is overbought, suggesting a potential pullback. However, the price is above both the 30-day (MA30: 175.36) and 50-day (MA50: 176.94) moving averages, indicating a bullish trend. Directional Bias: Despite the overbought RSI, the stock remains in a strong upward trend, supported by its recent performance near the 60-day high of $199.66. The distance from the 60-day low of $144.26 also reinforces the bullish sentiment. Trade Plan: - Suggested Entry: $193.34 - Stop Loss: $186.94 (below recent support) - Take Profit Targets: 1. $199.00 (3% gain) 2. $205.00 (6% gain) 3. $227.00 (17% gain) This plan allows for a strategic approach, leveraging the current momentum while managing risk effectively. https://privateprofiteers.com
0 · Reply
madisonclark03
madisonclark03 Dec. 11 at 7:44 PM
$CRL Mainz Biomed has the perfect trap setup for late shorts: they see a dead $1 stock, but once 1.12–1.15 breaks, borrow dries up and the squeeze writes the story 📈😈
0 · Reply
Sam201
Sam201 Dec. 10 at 8:34 PM
$CRL short this!
1 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 3:49 AM
Actionable Trade Alert for $CRL: Market Context: $CRL is currently trading at $185.99, exhibiting strong upward momentum with an RSI of 81.6, indicating it is overbought. The price is significantly above the MA30 (174.69) and MA50 (175.71), suggesting a bullish trend but caution is warranted due to the high RSI. Directional Bias: The bullish trend is supported by the recent high of $199.66, which is close to the current price. However, the overbought RSI signals potential for a pullback. Trade Plan: - Suggested Entry: $185.99 - Stop Loss: $179.73 (1 ATR below the entry) - Take Profit Targets: 1. $192.00 (3.3% ROI) 2. $197.00 (5.5% ROI) 3. $218.00 (17.1% ROI) Target 3 offers a significant ROI, capitalizing on the potential for further upward movement while managing risk with a defined stop loss. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 11:37 PM
Actionable Trade Alert for $CRL: Market Context: $CRL is currently experiencing strong bullish momentum, evidenced by a high RSI of 84.21, indicating overbought conditions. The stock's last close at $188.35 is significantly above both the 30-day (MA30: 175.04) and 50-day (MA50: 174.96) moving averages, suggesting upward momentum. The recent 60-day high of $199.66 provides a potential resistance level. Directional Bias: The high RSI indicates a potential pullback, but given the strong trend above key moving averages, a breakout above the 60-day high could lead to further gains. Trade Plan: - Suggested Entry: $188.35 - Stop Loss: $180.20 (approximately 4.3% below entry) - Take Profit Targets: 1. Target 1: $195.00 (3.5% gain) 2. Target 2: $198.00 (5.2% gain) 3. Target 3: $220.00 (16.8% gain) With a well-defined stop loss and clear targets, this trade offers a potential ROI of over 17% on the third target. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:37 AM
Actionable Trade Alert for $CRL: Market Context: $CRL closed at $184.04, showing strong momentum with an RSI of 68.73, indicating it is nearing overbought territory. The stock is above both the 30-day MA (175.55) and the 50-day MA (173.39), suggesting bullish sentiment. The 60-day high of $199.66 provides a key resistance level, while the low of $144.26 indicates potential support. Directional Bias: Given the current price action and the proximity to the 60-day high, there is a bullish bias, but caution is warranted due to the elevated RSI. Trade Plan: - Suggested Entry: $185.00 - Stop Loss: $178.00 (4% below entry) - Take Profit Targets: 1. $192.00 (3.78% gain) 2. $197.00 (6.45% gain) 3. $216.00 (16.5% gain) This plan offers a potential ROI of over 17% on the third target while maintaining a manageable risk. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:12 PM
Actionable Trade Alert for $CRL: Market Context: $CRL closed at $184.04, showing strong momentum with an RSI of 68.73, indicating it is nearing overbought territory. The stock is above both the 30-day MA (175.55) and the 50-day MA (173.39), suggesting bullish sentiment. The 60-day high of $199.66 provides a key resistance level, while the low of $144.26 indicates potential support. Directional Bias: Given the current price action and the proximity to the 60-day high, there is a bullish bias, but caution is warranted due to the elevated RSI. Trade Plan: - Suggested Entry: $185.00 - Stop Loss: $178.00 (4% below entry) - Take Profit Targets: 1. $192.00 (3.78% gain) 2. $197.00 (6.45% gain) 3. $216.00 (16.5% gain) This plan offers a potential ROI of over 17% on the third target while maintaining a manageable risk. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 4 at 7:15 PM
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 4 at 7:05 PM
$CRL Current Stock Price: $184.70 Contracts to trade: $185 CRL Dec 19 2025 Call Entry: $4.60 Exit: $9.19 ROI: 100% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Estimize
Estimize Dec. 3 at 1:09 PM
Wall St is expecting 2.34 EPS for $CRL Q4 [Reporting 02/18 BMO] http://www.estimize.com/intro/crl?chart=historical&metric_name=eps&utm_cont
0 · Reply
OpenOutcrier
OpenOutcrier Nov. 21 at 9:00 PM
RECAP 11/21 Chatter: $NVDA + Trump H200 China $CRL - CDC end Monkey tests RECAP 11/21 +Pos Comments: $FUTU + Citi $LGN + Tigress RECAP 11/21 -Neg Comments: $UPM - Barclays $IPAR - BWS Financial Live Breaking trading news www.openoutcrier.com
0 · Reply